| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.64B | $2.54B | $2.33B |
| YoY Revenue Growth % | +4.1% | +9.1% | — |
| Gross Profit | $568.4M | $485.5M | — |
| Gross Margin % | 21.5% | 19.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $304.6M | $246.3M | $181.3M |
| Operating Margin % | 11.5% | 9.7% | 7.8% |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | $393.4M | $332.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $318.9M | $203.2M | $210.0M |
| Capital Expenditures (CapEx) | $111.0M | $107.1M | — |
| Free Cash Flow (FCF) | $207.8M | $96.1M | $210.0M |
| FCF Margin % | 7.9% | 3.8% | 9.0% |
| Return on Invested Capital (ROIC %) | 27.7% | 27.8% | — |
| Cash & Short-Term Equivalents | $688.9M | $497.5M | — |
| Total Debt (Short + Long Term) | $487.4M | $482.0M | — |
| Total Stockholders' Equity | $1.07B | $714.3M | — |